Roles of Gut Microbiota in Alcoholic Liver Disease
International Journal of General Medicine · 2023-08 · Volume 16 · 3735-3746
DOI: 10.2147/ijgm.s420195 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of General Medicine, 2023-08. Verfasst von Daya Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School, Hainan Medical University, Haikou, People's Republic of China. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Alcoholic liver disease (ALD)-one of the most common liver diseases - involves a wide range of disorders, including asymptomatic hepatic steatosis, alcoholic hepatitis (AH), liver fibrosis, and cirrhosis. Alcohol consumption induces a weakened gut barrier and changes in the composition of the gut microbiota. The presence of CYP2E1 and its elevated levels in the gastrointestinal tract after alcohol exposure lead to elevated levels of ROS and acetaldehyde, inducing inflammation and oxidative damage in the gut. At the same time, the influx of harmful molecules such as the bacterial endotoxin LPS and peptidogly from gut dysbiosis can induce intestinal inflammation and oxidative damage, further compromising the intestinal mucosal barrier. In this process, various oxidative stress-mediated post-translational modifications (PTMs) play an important role in the integrity of the barrier, eg, the presence of acetaldehyde will result in the sustained phosphorylation of several paracellular proteins (occludin and zona occludens-1), which can lead to intestinal leakage. Eventually, persistent oxidative stress, LPS infiltration and hepatocyte damage through the enterohepatic circulation will lead to hepatic stellate cell activation and hepatic fibrosis. In addition, probiotics, prebiotics, synbiotics, fecal microbial transplantation (FMT), bioengineered bacteria, gut-restricted FXR agonists and others are promising therapeutic approaches that can alter gut microbiota composition to improve ALD. In the future, there will be new challenges to study the interactions between the genetics of individuals with ALD and their gut microbiome, to provide personalized interventions targeting the gut-liver axis, and to develop better techniques to measure microbial communities and metabolites in the body.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Graduate School, Hainan Medical University, Haikou, People's Republic of China.
- Department of Gastroenterology, The Second Affiliated Hospital of Hainan Medical University, Haikou, People's Republic of China.
- The Gastroenterology Clinical Medical Center of Hainan Province, Haikou, People's Republic of China.
ORCID-Profile: Daya Zhang
Zitieren
APA
Zhang, D., Liu, Z., & Bai, F. (2023). Roles of Gut Microbiota in Alcoholic Liver Disease. International Journal of General Medicine, Volume 16, 3735-3746. https://doi.org/10.2147/ijgm.s420195
Vancouver
Zhang D, Liu Z, Bai F. Roles of Gut Microbiota in Alcoholic Liver Disease. International Journal of General Medicine. 2023;Volume 16:3735-3746. doi:10.2147/ijgm.s420195
BibTeX
@article{Zhang2023,
author = {Zhang, Daya and Liu, ZhengJin and Bai, Feihu},
title = {Roles of Gut Microbiota in Alcoholic Liver Disease},
journal = {International Journal of General Medicine},
year = {2023},
volume = {Volume 16},
pages = {3735--3746},
doi = {10.2147/ijgm.s420195}
}
EUVIMED